The peanut tablet spearheads ALK's future portfolio in food allergy, which also spans novel concepts in pre-clinical development targeting other pathways and indications. ALK-Abelló A/S For further ...

ALK’s peanut tablet shown to be safe and tolerable across multiple doses.Development now advances to phase II for dose finding and efficacy.

ALK translocations are found in approximately ... cell growth and proliferation through the activation of apoptotic pathways. Researchers believe the results of this preclinical work support ...

"Positive preclinical data indicate that REQORSA in combination with ALK inhibitors may provide ... action whereby it interrupts cell signaling pathways that cause replication and proliferation ...

"Positive preclinical data indicate that REQORSA in combination with ALK inhibitors may provide benefit to patients ... cell growth and proliferation through the activation of apoptotic pathways.

D/Quarters, the provider of state-of-the-art co-working spaces by TECOM Group PJSC, has doubled the size of its centrally located offices at Dubai Science Park to address rising demand for agile and ...

Dr. Alison Moskowitz presented results of a Phase 1 study of combination duvelisib plus ruxolitinib in relapsed/refractory (R ...

Receptors such as EGFR, HER2, MET and ALK interface with common downstream signaling pathways and 'addiction switching' can occur, either by the inhibition of one receptor triggering a switch to ...